BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27707924)

  • 1. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
    Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
    J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuated Human Parainfluenza Virus Type 1 Expressing Ebola Virus Glycoprotein GP Administered Intranasally Is Immunogenic in African Green Monkeys.
    Lingemann M; Liu X; Surman S; Liang B; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
    J Virol; 2017 May; 91(10):. PubMed ID: 28250127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection.
    Isono M; Furuyama W; Kuroda M; Kondoh T; Igarashi M; Kajihara M; Yoshida R; Manzoor R; Okuya K; Miyamoto H; Feldmann H; Marzi A; Sakaitani M; Nanbo A; Takada A
    Antiviral Res; 2020 Nov; 183():104932. PubMed ID: 32946918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebola Virus Glycoprotein Strongly Binds to Membranes in the Absence of Receptor Engagement.
    Vaknin A; Grossman A; Durham ND; Lupovitz I; Goren S; Golani G; Roichman Y; Munro JB; Sorkin R
    ACS Infect Dis; 2024 May; 10(5):1590-1601. PubMed ID: 38684073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing.
    Shrivastava-Ranjan P; Flint M; Bergeron É; McElroy AK; Chatterjee P; Albariño CG; Nichol ST; Spiropoulou CF
    mBio; 2018 May; 9(3):. PubMed ID: 29717011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus.
    Zhang Y; Zhang M; Wu H; Wang X; Zheng H; Feng J; Wang J; Luo L; Xiao H; Qiao C; Li X; Zheng Y; Huang W; Wang Y; Wang Y; Shi Y; Feng J; Chen G
    Elife; 2024 Mar; 12():. PubMed ID: 38526940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ectodomain shedding of the glycoprotein GP of Ebola virus.
    Dolnik O; Volchkova V; Garten W; Carbonnelle C; Becker S; Kahnt J; Ströher U; Klenk HD; Volchkov V
    EMBO J; 2004 May; 23(10):2175-84. PubMed ID: 15103332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Niemann-Pick C1 Heterogeneity of Bat Cells Controls Filovirus Tropism.
    Takadate Y; Kondoh T; Igarashi M; Maruyama J; Manzoor R; Ogawa H; Kajihara M; Furuyama W; Sato M; Miyamoto H; Yoshida R; Hill TE; Freiberg AN; Feldmann H; Marzi A; Takada A
    Cell Rep; 2020 Jan; 30(2):308-319.e5. PubMed ID: 31940478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody Derived Peptides for Detection of Ebola Virus Glycoprotein.
    Rodríguez-Martínez LM; Marquez-Ipiña AR; López-Pacheco F; Pérez-Chavarría R; González-Vázquez JC; González-González E; Trujillo-de Santiago G; Ponce-Ponce de León CA; Zhang YS; Dokmeci MR; Khademhosseini A; Alvarez MM
    PLoS One; 2015; 10(10):e0135859. PubMed ID: 26489048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Techniques and tactics used in determining the structure of the trimeric ebolavirus glycoprotein.
    Lee JE; Fusco ML; Abelson DM; Hessell AJ; Burton DR; Saphire EO
    Acta Crystallogr D Biol Crystallogr; 2009 Nov; 65(Pt 11):1162-80. PubMed ID: 19923712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing.
    Banerjee S; Hemmat MA; Shubham S; Gosai A; Devarakonda S; Jiang N; Geekiyanage C; Dillard JA; Maury W; Shrotriya P; Lamm MH; Nilsen-Hamilton M
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyanovirin-N Binds Viral Envelope Proteins at the Low-Affinity Carbohydrate Binding Site without Direct Virus Neutralization Ability.
    Maier I; Schiestl RH; Kontaxis G
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34199200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein M.
    Blondeau C; Pelchen-Matthews A; Mlcochova P; Marsh M; Milne RS; Towers GJ
    J Virol; 2013 Dec; 87(24):13124-33. PubMed ID: 24067975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of Outbreak-Specific Nonsynonymous Mutations on Ebolavirus GP in the Context of Known Immune Reactivity.
    Vaughan K; Xu X; Peters B; Sette A
    J Immunol Res; 2018; 2018():1846207. PubMed ID: 30581874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting host O-linked glycan biosynthesis affects Ebola virus replication efficiency and reveals differential GalNAc-T acceptor site preferences on the Ebola virus glycoprotein.
    Bagdonaite I; Abdurahman S; Mirandola M; Pasqual D; Frank M; Narimatsu Y; Joshi HJ; Vakhrushev SY; Salata C; Mirazimi A; Wandall HH
    J Virol; 2024 May; ():e0052424. PubMed ID: 38757972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2-mediated enhancement of Ebola virus entry.
    Kuroda M; Halfmann P; Kawaoka Y
    PLoS Pathog; 2020 Oct; 16(10):e1008900. PubMed ID: 33052961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebola virus, but not Marburg virus, replicates efficiently and without required adaptation in snake cells.
    Fedewa G; Radoshitzky SR; Chī X; Dǒng L; Zeng X; Spear M; Strauli N; Ng M; Chandran K; Stenglein MD; Hernandez RD; Jahrling PB; Kuhn JH; DeRisi JL
    Virus Evol; 2018 Jul; 4(2):vey034. PubMed ID: 30524754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry.
    Radoshitzky SR; Longobardi LE; Kuhn JH; Retterer C; Dong L; Clester JC; Kota K; Carra J; Bavari S
    PLoS One; 2011; 6(7):e21398. PubMed ID: 21750710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evolution and determinants of neutralization of potent head-binding antibodies against Ebola virus.
    Yu X; Hastie KM; Davis CW; Avalos RD; Williams D; Parekh D; Hui S; Mann C; Hariharan C; Takada A; Ahmed R; Saphire EO
    Cell Rep; 2023 Nov; 42(11):113366. PubMed ID: 37938974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species-Specific Evolution of Ebola Virus during Replication in Human and Bat Cells.
    Whitfield ZJ; Prasad AN; Ronk AJ; Kuzmin IV; Ilinykh PA; Andino R; Bukreyev A
    Cell Rep; 2020 Aug; 32(7):108028. PubMed ID: 32814037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.